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Abstract
Preterm birth is the major cause of neonatal mortality and morbidity. In many cases, it has severe life-long consequences for
the health and neurological development of the newborn child. More than 50% of all preterm births are spontaneous, and
currently there is no effective prevention. Several studies suggest that genetic factors play a role in spontaneous preterm
birth (SPTB). However, its genetic background is insufficiently characterized. The aim of the present study was to perform a
linkage analysis of X chromosomal markers in SPTB in large northern Finnish families with recurrent SPTBs. We found a
significant linkage signal (HLOD =3.72) on chromosome locus Xq13.1 when the studied phenotype was being born
preterm. There were no significant linkage signals when the studied phenotype was giving preterm deliveries. Two
functional candidate genes, those encoding the androgen receptor (AR) and the interleukin-2 receptor gamma subunit
(IL2RG), located near this locus were analyzed as candidates for SPTB in subsequent case-control association analyses. Nine
single-nucleotide polymorphisms (SNPs) within these genes and an AR exon-1 CAG repeat, which was previously
demonstrated to be functionally significant, were analyzed in mothers with preterm delivery (n= 272) and their offspring
(n= 269), and in mothers with exclusively term deliveries (n= 201) and their offspring (n= 199), all originating from northern
Finland. A replication study population consisting of individuals born preterm (n= 111) and term (n= 197) from southern
Finland was also analyzed. Long AR CAG repeats ($26) were overrepresented and short repeats (#19) underrepresented in
individuals born preterm compared to those born at term. Thus, our linkage and association results emphasize the role of
the fetal genome in genetic predisposition to SPTB and implicate AR as a potential novel fetal susceptibility gene for SPTB.
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Introduction
Preterm birth (birth before 37 completed weeks of gestation) is a
major global healthcare problem, affecting approximately 13 mil-
lion people every year [1]. Approximately 12% of all infants are
born preterm in the United States; this figure is 6% in Europe [2].
Seventy percent of mortality and 75% morbidity in the neonatal
period are caused by preterm birth, and preterm infants also face a
substantial risk of several serious morbidities that may have life-
long consequences [3]. Multiple gestation, maternal chronic
diseases, fetal malformations, and infections are among the factors
known to increase the risk of preterm birth [4]. Preterm birth
tends to recur in families, with mothers with previous preterm
deliveries being at a significantly increased risk of preterm delivery
in subsequent pregnancies [5–9]. Preterm birth also occurs across
generations and sibships, with the risk of preterm delivery shared
between mothers and daughters, and sisters [7,8,10–13]. Aggre-
gation of preterm deliveries in families suggests a significant role
for genetic factors in preterm birth. Approximately 70% of all
preterm births are spontaneous, and no environmental risk factor
can be identified for most of these births [4]. Thus, it is likely that
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several spontaneous preterm births (SPTBs) are explained by
genetic factors.
Because initiation of parturition is preceded by physiological
changes occurring in both the mother and fetus, it is possible that
both maternal and fetal genes may predispose to preterm birth
[14]. Most large population-based studies suggest that maternal
genetic factors play the most significant role with little or a
substantially smaller contribution of the fetal genes [8,12,13].
Some genetic modeling studies have further estimated that, in
addition to environmental factors, the variation in gestational age
is explained by both maternal and fetal genetic factors [15–17],
while other studies have failed to find a significant contribution of
the fetal genes [12,13]. Overall, these studies suggest that the
genetic influences of SPTB are most likely to be either direct
effects of maternal genes acting in the mother, of maternally-
inherited mitochrondrial genes acting in the fetus, or of
maternally-inherited fetal genes. Knowledge about the actual
genes predisposing to SPTB is insufficient. So far, the significance
of specific candidate genes in SPTB has been assessed in numerous
case-control studies [18], focusing mostly on genes involved in the
infection and inflammation pathway, such as those encoding
tumor necrosis factor a (TNF-a) and several interleukins [19–23].
Although significant associations of both maternal and fetal
genetic factors have been reported in several studies, most of the
studies have been limited in several respects, including small
sample sizes, inconsistent phenotype definitions, and failure to
replicate in subsequent studies and across populations [18]. Recent
more comprehensive association studies have implied a role for
genes involved in multiple pathways in SPTB emphasizing the
heterogeneity in the SPTB phenotype; these associating genes
include the maternal FSHR and TIMP2 genes, encoding follicle-
stimulating hormone receptor and tissue inhibitor of metallopro-
teinase 2, respectively [24,25], and the fetal IL6R and COL5A2
genes, encoding interleukin-6 receptor and collagen type V, alpha
2, respectively [25,26]. To date, genome-wide case-control
association analyses of SPTB have not been reported.
Recently, we reported the results of the first linkage analysis of
SPTB in seven large northern Finnish families with recurrent
SPTBs using a high-density array of autosomal markers [27]. The
gene encoding insulin-like growth factor receptor 1 (IGF-1R) was
identified as a potential SPTB-predisposing gene. In the present
study, linkage analysis was performed for these same families using
X chromosomal markers. After linkage analysis, two genes,
encoding the androgen receptor (AR) and the interleukin-2
receptor gamma subunit (IL2RG), located near a significant
linkage signal were further analyzed as candidates for SPTB in
case-control populations originating from northern and southern
Finland.
Materials and Methods
Ethics Statement
The study was approved by the Ethics Committees of Oulu
University Hospital and Helsinki University Central Hospital.
Written informed consent was obtained from the subjects
participating in the study.
Study Populations
Definition of SPTB and inclusion criteria for the SPTB
cases. SPTB was defined as spontaneous preterm birth occur-
ring before 36 completed weeks of gestation. Preterm deliveries
occurring both with intact membranes and those following
preterm premature rupture of fetal membranes (PPROM, defined
as leakage of amniotic fluid as the presenting symptom before the
onset of contractions) were included among the SPTBs. Deliveries
involving known risk factors for preterm birth (multiple gestation,
polyhydramnios, septic or acute systemic infection of the mother,
diseases of the mother that possibly affect the pregnancy outcome
including those influencing cardio-pulmonary, hepato-renal, or
endocrine functions, and chronic inflammatory disease, alcohol or
narcotic use, accidents, and fetuses with congenital anomalies) and
all medically indicated preterm births without labor (preeclampsia,
intrauterine growth restriction, and placental abruption) were
excluded. All analyzed subjects were of Finnish origin. The overall
rate of preterm birth is approximately 5.5% in Finland [28].
Considering that approximately 70% of all preterm deliveries are
spontaneous and that some spontaneous deliveries were further
excluded from our study due to border-line gestational ages (birth
at gestational age ranging from 36 weeks + 0 days to 36 weeks +
6 days; approximately 35% of all preterm births), multiple
gestation (approximately 30% of all preterm births and 15% of
all deliveries with a spontaneous onset) or any of the other above-
mentioned exclusion criteria (leading to exclusion of approximate-
ly 15% of all deliveries), the proportion of all preterm deliveries
fulfilling our selection criteria is estimated to be approximately
20%, which corresponds to approximately 1.1% of all births in
Finland.
Families in Linkage Analysis. The families used in the
current study were the same as those used in our recently
published linkage study performed with autosomal markers [27].
Families with recurrent SPTB were selected retrospectively from
birth diaries of Oulu University Hospital during 197322003, and
prospectively during 200322005. Family interviews revealed 20
large families with SPTBs in two or more generations or in first
cousins. To ensure that the families were nonconsanguineous, a
genealogical study was performed according to published criteria
[29]. An examination of the microfiche copies available in the
provincial and national archive of Finland did not reveal close
consanguinity or common residence dating from the 17th century
among the families. Finally, the families with apparent maternal
inheritance of the SPTB phenotype were selected for the study
because most previous family studies suggest that maternal genes
or maternal genes acting in the fetus (rather than paternal)
influence the duration of pregnancy and the inheritance of
preterm delivery [8,12,13,16]. Whole-blood DNA samples (n=89)
were collected from as many family members as possible. The
pedigrees of the seven families in the linkage analysis are depicted
in Figure 1; gestational ages and years of birth for the family
members born preterm are shown in Table S1.
Study Sample in the Initial Case-Control Association
Analysis. Mothers with one or more spontaneous preterm
deliveries and their preterm offspring (born at ,36 gestational
weeks) born in the Oulu University Hospital region (northern
Finland) were selected for the study during the same time period as
the linkage analysis families. Cases included mothers and their
offspring from both families with multiple (two or more) SPTBs as
well as those with a single SPTB in the family. For 39 families with
multiple SPTBs, DNA samples of two or more individuals born
preterm were available. To include deliveries involving as few as
possible other than genetic risk factors for SPTB, a single
individual born preterm was selected for analysis from these
families according to the following low-risk criteria: 1) age of the
mother between 20 and 35 years at the time of the birth of the
individual born preterm (criterion applied because low and high
maternal ages are risk factors for preterm birth [4]; 9 individuals
selected using this criterion), and 2) no deliveries within the
preceding 2 years, or the longest time interval from the previous
delivery (criterion applied because short inter-pregnancy interval is
Linkage Analysis of X Chromosome in Preterm Birth
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a risk factor for preterm birth [4]; 22 individuals selected using this
criterion). If these criteria were not applicable, a female individual
was selected over a male individual (criterion applied because a
somewhat higher proportion of male fetuses are born preterm
compared to female fetuses [30]; 8 individuals selected using this
criterion). None of the SPTB cases were members of any of the
linkage analysis families. The clinical characteristics of the case
study population are shown in Table 1. Whole-blood or buccal
Figure 1. Pedigrees of the seven families with recurrent spontaneous preterm births analyzed in the linkage analysis of X
chromosomal markers. Individuals born preterm are shown by half-black symbols. Squares represent males and circles females. Individuals
analyzed in the linkage analysis are indicated by a number (n= 89). The diamonds denote an unspecified number of term infants, the smaller
diamonds with a line through the symbol represent a miscarriage, and the lines through the other symbols indicate that the person is deceased.
Gestational ages and years of birth for the family members born preterm are shown in Table S1. Linkage analysis was performed in two settings: 1)
being spontaneously born preterm as the phenotype (affected offspring phenotype, naffected =41), and 2) giving spontaneous preterm births as the
phenotype (affected mother phenotype, naffected =21). These pedigrees have been previously shown in the supplementary material of our linkage
study of SPTB performed using autosomal markers [27].
doi:10.1371/journal.pone.0051378.g001
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samples were obtained from cases (141 whole-blood and 131
buccal samples of SPTB mothers; 104 whole-blood and 165 buccal
samples of SPTB offspring), and when available, also from fathers
(n=226; 117 whole-blood and 109 buccal samples). The control
population comprised mothers with exclusively at least three term
(gestational age $37 wk) deliveries (n=201) without any preg-
nancy- or labor-associated complications (intrauterine growth
restriction, placental abruption, polyhydramnios, preeclampsia,
fetuses with congenital anomalies, requirement of special care of
the newborn) and their singleton offspring (n=199; 110 males and
89 females) collected prospectively following delivery in the Oulu
University Hospital during 200422007. The selection criterion
‘‘exclusively at least three term deliveries’’ was applied because
women who have had several uncomplicated term deliveries
without any preterm deliveries are likely to be at low risk to give
birth preterm in subsequent pregnancies and thus most unlikely to
carry genetic factors that predispose to SPTB. Whole-blood or
buccal samples were obtained from controls (143 whole-blood and
58 buccal samples of control mothers; 199 whole-blood samples of
control offspring).
Replication Study Sample for the Case-Control
Association Analysis. Due to a significant linkage signal with
the affected offspring phenotype and association of a fetal
polymorphism in the initial case-control population, a replication
study sample consisting of individuals born preterm (at ,36
gestational weeks; n=111; 56 males and 55 females) and term
(n=197; 94 males and 103 females) collected in the Helsinki
University Central Hospital (southern Finland) during 200522008
was analyzed. The cases (SPTB offspring) were selected using the
same criteria as described for the initial study sample. Similarly to
the initial offspring control population, the replication control
population was comprised of individuals born at gestational age
$37 wk for mothers who had experienced no pregnancy-or labor-
associated complications. However, it should be noted that the
replication control study sample did not meet one of the criteria
for the selection of the initial controls, that is, the occurrence of
exclusively at least three term deliveries in the family. Whole-blood
samples were obtained from cases and controls.
DNA Sample Preparation
Genomic DNA was extracted from whole blood or buccal cells
using standard methods as described [27]. Buccal DNA was
whole-genome amplified (WGA) using the Illustra GenomiPhi V2
DNA Amplification kit (GE Healthcare Sciences, Cardiff, UK)
and purified using Illustra Microspin G-50 columns (GE
Healthcare Sciences). Nontemplate reactions were included in
the WGA reactions to control for contamination. The quality of
the WGA samples was controlled in the set-up stage by genotyping
amplified DNA samples in duplicate reactions simultaneously with
the corresponding unamplified samples and whole-blood DNA
samples obtained from the same individuals using a test set of
single-nucleotide polymorphisms (SNPs); this yielded .99%
consistent genotypes. Samples with low genotyping success rate
were further excluded from analyses.
Genotyping and Data Analysis in the Linkage Study
DNA samples for the linkage analysis were genotyped in the
Broad Institute Center for Genotyping and Analysis (CGA) using
the Affymetrix Genome-Wide Human SNP Array 5.0Kb.
Before linkage analysis, the Affymetrix SNP array data was
processed using PLINK, v. 1.02 [31]. A 1-Mb-to-1 cM map was
used as justified before [32]. SNPs occurring at a minor allele
frequency (MAF) ,0.08 in the studied subjects, genotyping failure
.0.1, Mendelian errors, or deviation from HWE (p,0.001) were
excluded. The absence of Mendelian errors was confirmed using
Pedcheck [33]. After these pruning steps, 4,870 X chromosomal
SNPs with an average spacing of 0.031 Mb remained for linkage
analysis.
Linkage analysis of X chromosomal markers was performed in
two settings: 1) being spontaneously born preterm as the
phenotype (affected offspring phenotype, naffected =41), and 2)
giving spontaneous preterm births as the phenotype (affected
mother phenotype, naffected =21). Two-point linkage analysis was
applied to avoid bias potentially arising in multipoint analyses due
to markers displaying linkage disequilibrium (LD) or missing
parental genotype data [34]. We used a dominant, low-penetrance
model with a disease allele frequency set to 0.001 and penetrances
of 0.001 for the homozygotes, 0.001 for the heterozygotes and 0
Table 1. Clinical characteristics of the case study populations of spontaneous preterm birth.
Initial population from northern Finland
Replication population from
southern Finland
Characteristic Offspring Mothers Offspring
Total n 269a 272a 111
Single spontaneous preterm delivery in the family, n 194 199 95
Two spontaneous preterm deliveries in the family, n 60 57 16
3–5 spontaneous preterm deliveries in the family, n 15 16 0
Gestational age, wk 31.862.99 (24.1–35.9)b 34.061.92 (27.6–35.9)b
Gestational age ,32 wk, n 109 15
Gestational age $32 wk, n 160 96
Birth weight, g 1,8646618 (538–3,070)b 2,3616492 (1,130–3,598)b
PPROM, yes/no 111/158 67/44
Male/female 149/120 56/55
Maternal smoking during pregnancy, yes/no/unknown 34/170/65 33/175/64 6/105/0
aMismatch in the numbers of mothers and offspring is due to occasional low quality of DNA samples.
bMean 6 standard deviation (range).
doi:10.1371/journal.pone.0051378.t001
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for the wild-type homozygotes. The effect of misspecifying the
actual mode of inheritance (MOI) is minimized in this model.
Therefore, this model is nearly equivalent to a model-free analysis
while the high power of parametric analysis to detect linkage is
retained [35,36]. Analyze, v. 1.9.3. BETA [37], which uses
FASTLINK 4.1P for calculation of pedigree likelihoods, was used
in parametric two-point linkage analysis of SPTB. Heterogeneity
LOD (HLOD) scores and the estimates of proportion of linked
families (a) and recombination fraction (h) were used to assess
parametric linkage in the presence of heterogeneity. An HLOD
score .3.3 was considered as a significant signal of linkage.
Selection of Genes For the Case-Control Study
Due to a significant linkage signal for marker rs6525299 on
chromosome locus Xq13.1, we screened the region (,5 Mb)
surrounding the linkage peak for the presence of plausible
candidate genes for SPTB and chose to analyze two genes near
this locus (AR and IL2RG, located upstream and downstream from
rs6525299, respectively, each at a distance of ,2 Mb) as
candidates for SPTB. The AR and IL2RG genes were chosen for
analysis based on their function: IL2RG, encoding for a signaling
component (the common gamma chain) of several interleukin
receptors with essential roles in the immunity [38], emerged as an
interesting candidate because infections are estimated to be
involved in approximately 30–40% of preterm births [39]; AR
emerged as an interesting candidate due to the role of androgen
receptor in the development of several tissues and due to
involvement of androgens in the biosynthesis of estrogen, which
is essentially involved in the regulation of parturition initiation
[40,41]. Altogether 65 and 41 SNPs (at an average SNP spacing of
0.03 Mb) analyzed in the Affymetrix linkage array were located
within the interval spanning from the most significant linkage peak
(rs6525299) to the AR and IL2RG genes, respectively. In linkage
analysis, suggestive or nearly suggestive linkage signals (HLODs
1.522.7) were detected for several SNPs located between the
linkage peak and these two genes, while some of the SNPs located
in this region showed no signals (data not shown). According to
1000 Genomes Project sequence data, SNP rs6525299 (the marker
yielding the significant linkage signal) occurs at a MAF of 0.16 in
the Finnish population, while many of the SNPs of the Affymetrix
linkage array located between this SNP and the AR and IL2RG
genes occur at a MAF of 0.2520.35. Ability to detect LD between
a SNP and a given genetic variant is influenced by allele
frequencies of these variants [42–44]. Thus, a SNP may display
linkage with a given genetic variant even though other markers
located close to this variant show weaker linkage signals.
Selection of Polymorphisms and Genotyping in the Case-
Control Study
Tagging SNPs (tSNPs) were selected for the AR and IL2RG
genes using HapMap data (release23a/phaseII) from the CEU
(CEPH; Utah residents with ancestry from northern and western
Europe) population. Using pairwise tagging with MAF and r2
cutoffs of 0.05 and 1.0, respectively, six tSNPs (rs5918757,
rs5919393, rs2361634, rs5918762, rs12014709, and rs5031002)
were identified for the AR gene. In addition, two exonic AR
polymorphisms were further selected for analysis due to previously
reported associations of these polymorphisms to pregnancy-related
conditions and/or due to reported functional consequences: the
AR exon-1 SNP rs6152 (Glu213Glu) was selected because it was
previously shown to associate with recurrent spontaneous abor-
tions [45], and the exon-1 CAG repeat polymorphism (CAGn) was
selected because previous studies have shown that this polymor-
phism affects the AR-mediated transactivation [46], correlates
with the concentration of androgens [47], and associates with
recurrent spontaneous abortions [48]. For the IL2RG gene, no
tSNPs were identified even with a MAF cutoff of 0. Therefore, we
analyzed all common SNPs (MAF .0.05) indicated for this gene
(rs4612655, rs4073907, rs11574625, rs7880291, and rs28743771)
in the dbSNP database (www.ncbi.nlm.nih.gov/SNP). After
validation of the genotyping procedure, one SNP in AR
(rs2361634) and two SNPS in IL2RG (rs4073970 and
rs11574625) were excluded from the analysis.
SNP genotyping was performed using the SNaPshot Multiplex
kit (Applied Biosystems, Carlsbad, CA, USA). The AR CAG
repeat was genotyped using fragment analysis. A DNA fragment
containing the CAG repeat (at physical position
66,763,874266,944,119 in chromosome X) in the AR gene was
amplified using the polymerase chain reaction (PCR) with the
forward and reverse primers 59-ACC GAG GAG CTT TCC
AGA AT-39 and 59-CTG GGA CGC AAC CTC TCT C-
39respectively. The primers were purchased from Oligomer
(Helsinki, Finland) and the forward primer was labeled with the
fluorescent 6-FAM dye. The sizes of the PCR fragments were
determined using the ABI3130xl Genetic Analyzer (Applied
Biosystems), and the GeneScan-500 LIZ Size Standard (Applied
Biosystems) was used as a size standard. The fragment lengths
were analyzed using the GeneMapper software, v. 3.7 (Applied
Biosystems). PCR resulted in fragments with sizes ranging from
300 to 393 bp. To determine the exact number of CAG repeats, a
part of the samples were sequenced. Sequencing revealed that
fragment analysis had resulted in a 12-bp downwards shift in the
actual size of the PCR products. To correct for this bias, the
fragment sizes were adjusted for the shift. The shortest and longest
PCR fragments (adjusted sizes of 312 and 405 bp) corresponded to
11 and 42 CAG repeats, respectively.
Statistical Analysis in the Case-Control Study
Quality control. Before association analysis, the case-control
data was checked for Mendelian inconsistencies using PedCheck
[33]. Any inconsistent genotypes were recoded as missing.
Analysis of SNP frequencies. SNP allele distributions were
analyzed with logistic regression (additive model) with sex as a
covariate using PLINK, v. 1.07 [31]. Genotypes of female
individuals were also analyzed under the dominant and recessive
models. Case-control comparisons of haplotypes were performed
using Haploview v. 4.2 [49].
Analysis of AR CAGn distribution. Differences in AR CAGn
distributions were analyzed using the nonparametric Mann-
Whitney U test using Predictive Analytics Software (PASW)
Statistics, v. 17.0.3 (IBM, SPSS, Inc.). To equalize the contribu-
tions of male and female alleles, the tests were performed with the
hemizygous males treated as homozygotes. The CAGn distribu-
tions were divided into quintiles and further analyzed using the
Pearson X2 test with PASW Statistics. The CAGn analyses were
replicated using biallelic means for the females. Family-based
association tests of CAGn were performed using Pseudomarker, v.
1.0.6b [50], and FBAT, v. 2.0.2c [51], under the dominant model.
Pseudomarker was used to test for linkage in the presence of LD
(linkage given LD test) in mother-father-offspring trios or mother-
offspring pairs; this test is analogous to the model-free transmission
disequilibrium test. Pseudomarker can handle missing parental
data and different data structures such as mixtures of singletons
and families jointly; therefore both the mother-father-affected
offspring trios and mother-control offspring pairs are informative
in this analysis. FBAT was further used to determine significances
in preferential transmission of individual CAGn alleles in mother-
father-affected offspring trios.
Linkage Analysis of X Chromosome in Preterm Birth
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Significance threshold and power consideration. Using
the Bonferroni correction to account for testing of ten polymor-
phisms (nine SNPs and the AR CAGn), a p value #0.005 was
considered significant in case-control comparisons. Power consid-
eration for the initial case-control study (considering multiple
testing of ten polymorphisms, alpha = 0.005; prevalence of 0.05;
MAFs ranging from 0.15 down to 0.05; allelic test under additive
model): the sample size was estimated to provide 80% power to
detect relative risks of 1.9222.55 and 2.8424.10 for the
heterozygous and homozygous genotypes, respectively, both in
the offspring and mothers.
Genome Coordinates
Chromosomal positions refer to NCBI Build 37.2 of the human
genome.
Web Resources
1000 Genomes Project: http://www.1000genomes.org.
Genetic Power Calculator: http://pngu.mgh.harvard.edu/
,purcell/gpc.
International HapMap project: www.hapmap.org.
Results
Some of these results were described in a preliminary form in
the Ph.D. thesis of the first author [52].
Linkage Analysis of X chromosomal Markers in SPTB
Seven northern Finnish families with recurrent SPTB were
selected for linkage analysis using stringent phenotypic criteria,
with deliveries involving known risk factors of SPTB excluded.
Because family studies suggest that maternal factors may play an
important role in the inheritance of SPTB [8,12,13,16], only
families with apparent maternal inheritance were included.
Genealogical surveys ensured that the selected families were not
consanguineous.
Parametric two-point linkage analysis of SPTB was performed
using a high-density panel of X chromosomal markers. HLOD
scores are depicted in Figure 2. For the affected offspring
phenotype, a significant linkage signal was obtained for SNP
rs6525299 (h=0.00, a=1.00) on chromosome locus Xq13.1
(HLOD =3.72). HLOD scores for the three markers that yielded
the highest signals in linkage analysis are shown separately for each
of the families in Table 2. Two families (126 and 253) displayed
HLOD scores of 0.00 for these markers, indicating that there was
no evidence of linkage in these families. For the affected mother
phenotype, no significant linkage signals were detected (Figure 2);
HLODmax of 1.83 was detected for SNP rs4240068 on Xq21.2.
Case-Control Association Analysis of AR and IL2RG
Polymorphisms in the Initial SPTB Study Population
Originating from Northern Finland
The genes investigated as candidates for SPTB were selected
based on the location of the marker giving the significant signal in
linkage analysis. Based on their function, two genes located near
the marker yielding the maximum HLOD in linkage analysis
(rs6525299) emerged as interesting candidates for SPTB: those
encoding androgen receptor (AR, MIM *313700, located on
Xq12) and interleukin-2 receptor gamma subunit (IL2RG, MIM
*308380, located on Xq13.1). These genes are located at a
distance of approximately 2 Mb from SNP rs6525299.
Case-control association analysis of the selected genes in SPTB
was performed in a population consisting of mothers with preterm
and term deliveries and their preterm and term-born offspring,
respectively. Tagging SNPs representative of common variation
within each gene were selected using the HapMap CEU
population. In addition, other polymorphisms with potential
biological significance were included. For the offspring, the SNP
analyses were first performed in mixed-sex samples with sex as a
covariate. IL2RG SNP rs7880291 was not polymorphic in the
study population. Results of logistic regression analysis performed
for the AR and IL2RG SNPs are shown in Table 3; genotype
distributions of these polymorphisms did not differ between SPTB
and term mothers or offspring. Analysis of female individuals
under the dominant and recessive models did not reveal any
significant associations (data not shown). Five AR SNPs (rs6152,
rs5918757, rs5919393, rs5918762, and rs12014709) and two
IL2RG SNPs (rs4612544 and rs28743771) resided in haplotype
blocks. Altogether three 5-SNP AR haplotypes and two 2-SNP
IL2RG haplotypes with a frequency .0.01 were predicted
(Table 4). Analysis of these haplotypes did not reveal any
significant differences in haplotype frequencies between SPTB
offspring or mothers and their controls (Table 4).
The distributions of AR CAG repeat numbers in each group
studied are shown in Figure S1. The observed distributions are
consistent with those previously reported for individuals of
European descent [53]. Nearly all of the CAGn alleles in our
population were in the range of 13–30, which falls in the normal
range of repeat lengths (10–36). Very long alleles (38 or 42 repeats)
were detected in four individuals (two SPTB mothers and their
SPTB offspring). The median number of AR CAG repeats was 22
in all groups studied, except in female SPTB offspring, who had
median of 23. The distribution of CAG repeats differed
significantly between individuals born preterm and those born at
term (Mann Whitney U test, p=0.0006), with carriers of the
longest repeats ($26) being at a more than 2-fold risk (OR =2.45,
95% CI 1.46–4.13) of being born preterm compared to the
carriers of the shortest repeats (#19) (Table 5), suggesting that
longer alleles may predispose to SPTB. The difference was clearer
in females than in males (Table S2). Differences in CAGn
distributions between SPTB and term offspring were also
significant when biallelic means were used in the comparisons
(data not shown). There was no significant difference in the AR
CAGn distribution between SPTB mothers and mothers with term
deliveries (Mann-Whitney U test, p=0.13; mean 6 standard
deviation, SD, 22.4163.02 vs. 22.0662.81, respectively). The
fathers of the preterm offspring had a CAGn mean of 22.1562.75.
To evaluate whether the predisposing AR CAGn alleles had
been inherited from the mother or the father, distributions of
maternally and paternally inherited alleles were compared
between SPTB and term offspring. This revealed that distributions
of both maternally and paternally inherited CAGn alleles differed
between cases and controls; the difference was more significant for
the maternal alleles (Mann Whitney U test, p=0.0045, mean 6
SD, 22.5963.19 vs. 21.7462.63, respectively, for maternal alleles;
Mann Whitney U test, p=0.040, 22.7762.82 vs. 21.8462.72,
respectively, for paternal alleles). When the repeat lengths were
divided into quintiles, under- and overrepresentation of the lowest
and highest groups, respectively, could be seen in both maternally
and paternally inherited alleles (data not shown).
Family-based tests were performed to further investigate
whether specific CAGn alleles had been preferentially transmitted
to affected individuals, i.e. offspring born preterm. The linkage
given LD test showed evidence for disequilibrium in the
transmission of AR CAGn alleles (p=0.004), indicating that this
polymorphism is linked to the affected offspring phenotype in the
families of the case-control population. FBAT analysis further
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suggested that the allele with 19 repeats had been under-
transmitted and the allele with 24 repeats overtransmitted to
preterm-born offspring (Table 6), again suggesting that shorter
alleles may be protective and longer alleles predisposing to the
affected offspring phenotype.
Allele or haplotype frequencies of any of the studied polymor-
phisms, including AR CAGn, did not differ between SPTB mothers
or offspring with or without PPROM, according to gender, or
between individuals born very preterm (gestational age ,32 wk)
and moderately preterm (gestational age $32 wk) (data not
shown). The frequencies and AR CAGn distributions were similar
in offspring from families with multiple and single SPTBs (data not
shown).
Case-Control Association Analysis of AR and IL2RG
Polymorphisms in the Replication SPTB Study Population
Originating from Southern Finland
Because association analyses performed in the initial case-
control study population revealed an association of a fetal
polymorphism with SPTB, the case-control analyses were repeated
in a study population consisting of preterm and term offspring
originating from the southern Finland, where the population is
known to be genetically more diverse compared to northern
Finland [54]. Similarly to the initial population, none of the
analyzed AR and IL2RG SNPs associated with SPTB in the
replication population (data not shown). The range of the AR
CAGn repeats was 11–40. The allele with 40 repeats was detected
in a single individual born preterm while rest of the alleles were
#32 repeats in length. Similarly to the population of northern
Finland, the longer alleles tended to be more frequent in SPTB
than in term offspring but the difference in the distribution was not
significant (Mann Whitney U test, p=0.67; Table 5). However,
similarly to the northern Finnish population, carriers of the longest
CAG repeats ($26) were at a more than 2-fold risk (OR 2.25, 95%
CI 1.14–4.43) of being born preterm compared to the carriers of
the shortest repeats (#19) (Table 5), further suggesting that the
long fetal AR CAGn alleles may be involved in giving predispo-
sition to SPTB. Finally, when the populations of northern and
southern Finland were combined, the difference in CAGn
distribution between SPTB and term offspring was significant
(Mann Whitney U test, p = 0.0027; Table 5).
Figure 2. HLOD scores in parametric linkage analysis of X chromosomal markers in spontaneous preterm birth. HLODs for the affected
offspring phenotype are shown on the left and those for the affected mother phenotype on the right. The position of the marker yielding a
significant linkage signal (SNP rs6525299 on Xq13.1, HLOD of 3.72) for the affected offspring phenotype is shown. The position of the markers
yielding the second highest HLODs (SNPs rs11266953 and rs7056400 on Xq21.1, HLODs of 3.05) is also indicated. These three SNPs are intergenic.
doi:10.1371/journal.pone.0051378.g002
Table 2. SNPs with highest HLOD scores in parametric
linkage analysis of spontaneous preterm birth with the
affected fetus phenotype.
rs6525299 rs11266593 rs7056400
Locus Xq13.1 Xq21.1 Xq21.1
Physical position 68,623,050 80,124,948 80,173,940
Overall HLOD 3.72a 3.05a 3.05a
HLOD for each
family:
Family 24 0.42 0.01 0.01
Family 70 1.38 1.72 1.72
Family 126 0.00 0.00 0.00
Family 150 0.69 0.69 0.69
Family 185 0.80 0.20 0.20
Family 210 0.42 0.42 0.42
Family 253 0.00 0.00 0.00
ah= 0.00, a= 1.00.
doi:10.1371/journal.pone.0051378.t002
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Discussion
We recently reported the first linkage analysis of SPTB, which
was performed for autosomal markers in seven families with
recurrent SPTB [27]. In the present study, linkage analysis of X
chromosomal markers in these same families revealed a significant
linkage signal on chromosome locus Xq13.1 (HLOD of 3.72 for
SNP rs6525299) when the phenotype was being born preterm
(affected offspring phenotype). Two genes near this locus, AR and
IL2RG, were investigated in subsequent case-control association
analysis of mothers with preterm and term deliveries and their
offspring. Finally, our results indicated fetal AR as a novel gene
potentially involved in genetic predisposition to SPTB.
The length of the AR exon-1 CAG repeat was associated with
SPTB in the offpring, with longer repeat lengths overrepresented
in individuals born preterm compared to those born at term
(Table 5). AR is a nuclear receptor for the androgens testosterone
or dihydrosterone. It functions as a transcription factor regulating
expression of its target genes involved in the development of
several tissue, in maintenance of male sexual characteristics, and in
female reproductive physiology [40]. AR also has non-genomic
actions through interactions with signal transduction proteins in
the cytoplasm [55,56]. The AR CAG repeat encodes a polyglu-
tamine tract present in the transactivation domain of AR [46].
This domain is involved in ligand-induced transcriptional activity.
Longer polyglutamine chains have been shown to hinder the
transactivation activity of AR in vitro, while short polyglutamine
chains lead to enhanced AR activation resulting in hyperandro-
genism [46,57–59]. Thus, it is evident that the CAG repeat length
polymorphism has biologically significant consequences for AR
function.
AR has important roles during pregnancy and may be involved
in some pregnancy-related conditions. AR is widely expressed in
reproductive tissues of both males and females [60]. In developing
first-trimester human embryos, expression of AR has been
Table 3. Logistic regression analysis of AR and IL2RG polymorphisms in SPTB in the initial case-control population.
Minor allele frequency Logistic regression (additive model)
Gene and polymorphism Position SPTB Term p OR (95% CI)
Mothers n= 272 n=201
AR, rs6152 exon 1, Glu213Glu 0.146 0.150 0.88 0.97 (0.67–1.42)
AR, rs5918757 intron 1 0.139 0.154 0.55 0.89 (0.60–1.31)
AR, rs5919393 intron 1 0.148 0.154 0.80 0.95 (0.66–1.38)
AR, rs5918762 intron 3 0.139 0.145 0.80 0.95 (0.64–1.41)
AR, rs12014709 intron 5 0.047 0.067 0.22 0.70 (0.39–1.23)
AR, rs5031002 intron 6 0.006 0.025 0.03a 0.23 (0.06–0.86)
IL2RG, rs4612544 39 0.090 0.122 0.11 0.69 (0.45–1.09)
IL2RG, rs7880291 intron 1 0 0 - -
IL2RG, rs28743771 intron 1 0.095 0.124 0.17 0.73 (0.47–1.15)
Offspring n= 269 n=199
AR, rs6152 exon 1, Glu213Glu 0.126 0.126 1.00 1.00 (0.63–1.60)
AR, rs5918757 intron 1 0.118 0.122 0.87 0.96 (0.58–1.58)
AR, rs5919393 intron 1 0.128 0.126 0.94 1.02 (0.65–1.61)
AR, rs5918762 intron 3 0.106 0.113 0.79 0.93 (0.56–1.56)
AR, rs12014709 intron 5 0.053 0.042 0.55 1.23 (0.62–2.44)
AR, rs5031002 intron 6 0.006 0.020 0.15 0.29 (0.05–1.53)
IL2RG, rs4612544 39 0.102 0.102 0.99 1.00 (0.60–1.67)
IL2RG, rs7880291 intron 1 0 0 - -
IL2RG, rs28743771 intron 1 0.103 0.108 0.85 0.95 (0.57–1.59)
aNot significant at the Bonferroni-corrected significance level (p # 0.005 considered significant).
doi:10.1371/journal.pone.0051378.t003
Table 4. Association analysis of AR and IL2RG haplotypes in
SPTB in the initial case-control population.
Frequency
Gene Haplotype SPTB Term p
Mothers n= 272 n= 201
ARa GAACT 0.851 0.847 0.85
AGGTT 0.098 0.087 0.57
AGGTG 0.049 0.064 0.33
IL2RGb AA 0.907 0.876 0.13
GG 0.091 0.122 0.14
Offspring n= 269 n= 199
ARa GAACT 0.880 0.874 0.83
AGGTT 0.067 0.082 0.47
AGGTG 0.047 0.043 0.83
IL2RGb AA 0.899 0.891 0.73
GG 0.098 0.102 0.85
aSNPs in the haplotype: rs6152, rs5918757, rs5919393, rs5918762 and
rs12014709.
bSNPs in the haplotype: rs4612544 and rs28743771.
doi:10.1371/journal.pone.0051378.t004
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detected in several tissues, including several extragenital sites, such
as thymus, bronchial epithelium of the lung, spinal cord, and
cardiac valves [61]. AR levels in the fetal lung change significantly
with gestational age during mid- and late gestation [62]. Longer
AR CAG repeats (.19) have been shown to be overrepresented in
women with recurrent spontaneous abortions [48], and increased
AR expression has been detected in placentas of preeclamptic
women [63], suggesting that AR plays a role in these pregnancy-
related complications. Furthermore, successful induction of labor
by local prostaglandin treatment leads to decreased AR and
progesterone receptor levels in human uterine cervix [64]. This
suggests that besides the decrease in progesterone activity,
androgen withdrawal may be involved in the onset of parturition.
However, complete androgen insensitivity syndrome of the fetus
does not seem to lead to preterm birth [65]. Further studies on the
roles of AR exon-1 CAG repeat and the genes regulated by AR
could lead to further understanding of the function of fetal AR in
regulation of the onset of labor.
In our previous linkage study performed in the same families as
the present analysis, we found a significant linkage signal within
the gene encoding IGF1R and identified a 6-SNP haplotype within
this gene as a fetal susceptibility factor for SPTB [27].
Interestingly, recent studies have identified IGF1R as a down-
stream target for AR [66,67]. Furthermore, androgens have been
shown to be involved in activation of IGF1R through non-genomic
pathways involving AR [67–69]. In addition, hypermethylation of
the AR promoter may be involved in the progression of prostate
cancer and downregulate expression of IGF1R [67]. Because these
two genes were identified as fetal susceptibility factors for SPTB in
our previous and current studies, it is tempting to postulate that
interactions of these genes may affect the onset of spontaneous
preterm labor. However, further studies are needed to test this
hypothesis.
In the present study, we did not find significant linkage in the
mothers, i.e. when the phenotype was giving preterm deliveries.
This may be due to the small sample numbers in this analysis
(naffected =21) leading to low power to detect linkage. Previous
genetic modeling studies have estimated that both maternal and
fetal genetic effects contribute to the timing of parturition [15–17].
This is consistent with our finding of a fetal gene associated with
SPTB. However, several large population-based studies suggest a
significant contribution of maternal genes to preterm delivery with
little effect of fetal genes [8,12,13]. In a Dutch twin study, there
was no detectable evidence for paternal heritability of parturition
timing [70]. These studies suggest that paternal genes acting in the
fetus have little effect on the risk of preterm birth compared to
maternal genes acting either in the pregnant mother or in the
fetus. It remains to be investigated whether both maternal and
paternal alleles of the fetus could contribute to the SPTB
phenotype.
The strengths of our study include 1) the use of the family-based
linkage analysis for localization of the associating genomic region, 2)
the use of the northern Finnish population, which is known to be
genetically relatively homogeneous [54], 3) further analysis in the
genetically more diverse southern Finnish population, 4) analysis of
both the fetal and maternal contributions, and 5) stringent selection
criteria for the SPTB phenotype with deliveries involving major risk
Table 5. AR CAG repeat distributions in individuals born spontaneously preterm and in those born at term.
n Mean ± SDa
Mann-Whitney
U test, p
Frequency of repeats
in quintilesb
X2 test for
quintiles, p OR (95% CI)c
Oulu:
SPTB 252 22.5963.11 0.0006 0.109/0.282/0.260/0.208/0.141 0.009 2.45 (1.46–4.13)
Term 189 21.8762.64 0.201/0.267/0.275/0.151/0.106
Helsinki:
SPTB 111 22.4563.35 0.67 0.122/0.338/0.216/0.180/0.144 0.047 2.25 (1.14–4.43)
Term 197 22.0962.54 0.145/0.305/0.269/0.206/0.076
Combined
Oulu-Helsinki:
SPTB 363 22.5563.18 0.0027 0.113/0.299/0.247/0.200/0.142 0.0006 2.39 (1.58–3.60)
Term 386 21.9862.59 0.172/0.286/0.272/0.179/0.091
aMean 6 standard deviation of CAGn repeat length.
b1st quintile 10–19 repeats, 2nd quintile 20–21 repeats, 3rd quintile 22–23 repeats, 4th quintile 24–25 repeats, 5th quintile 26–42 repeats; frequencies shown separately for
male and female individuals in Table S2.
cORs for the highest quintile relative to the lowest quintile.
doi:10.1371/journal.pone.0051378.t005
Table 6. FBAT analysis of the AR CAGn polymorphism under
the dominant model in mother-father-preterm offspring trios
of the initial SPTB case population.
CAGn allele
(number of
repeats)a Number of families Zb p
18 31 20.180 0.857
19 20 22.236 0.025
20 42 1.234 0.217
21 56 21.336 0.181
22 42 1.234 0.217
23 41 20.469 0.639
24 28 1.890 0.059
25 46 0.000 1.000
26 25 20.200 0.841
27 11 20.905 0.366
aAnalysis was not performed for alleles with less than 10 transmissions.
bPositive and negative values of the FBAT test statistic Z are indicative of over-
and undertransmission, respectively.
doi:10.1371/journal.pone.0051378.t006
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factors for preterm birth excluded. In addition, our initial control
population consisted of mothers with exclusively at least three term
deliveries, and their offspring. These individuals therefore repre-
sented the so-called ‘‘super controls’’ for the SPTB phenotype. To
avoid false positives in the case-control study, the significances were
considered on the stringent Bonferroni-corrected level.
The limitations of our study include the relatively small number
of families in linkage analysis and the relatively small sample sizes
of both the initial case-control study population and particularly
that of the replication study population. Although association
between the fetal AR CAG repeat and SPTB was not directly
replicated in the southern Finnish population, the quintile
comparison suggested that, similarly to the northern Finnish
population, the longest alleles may be overrepresented in
individuals born preterm (Table 5). This analysis was apparently
limited by the small sample sizes in each of the quintile subgroups
in the southern Finnish population. However, because the
differences in the AR CAG distribution were significant when
the northern and southern Finnish populations were combined, we
feel that results of the southern Finnish population strengthened
the evidence for the role of fetal AR CAG repeat in genetic
predisposition to SPTB. Our study was also limited in that we only
analyzed two genes located near the linkage signal. Thus, we
cannot exclude the possibility that other genes located in the linked
region could play a role in SPTB. We also cannot exclude a
possible role for genes located near the suggestive linkage signals
on chromosome locus Xq21.1 (Figure 2) in SPTB. In the current
setting, we cannot evaluate whether the linkage signal actually was
due to linkage to AR CAGn polymorphism. Short tandem repeat
polymorphisms (STRPs), such as AR CAGn, are known to display
significant LD with SNPs even on long distances (up to 2 cM), and
STRP-SNP LD is greater on the X chromosome compared to
autosomes [44]. Therefore, it is possible that AR CAGn
polymorphism indeed is linked to SPTB. This conclusion is
further supported by the significant result of the family-based
linkage given LD test performed in the northern Finnish case-
control families in the present study. Further studies are needed to
evaluate the association between the fetal AR CAG repeat
polymorphism and SPTB; these should include replication in
other, more outbred populations and larger sample sizes.
In conclusion, we found the highest linkage signal (HLOD
=3.72) on chromosome Xq13.1 when the phenotype was being
born preterm. Two genes located near this locus, encoding the
androgen receptor (AR) and the interleukin-2 receptor gamma
subunit (IL2RG), were considered functional candidates for SPTB
and were thus analyzed in a subsequent case-control association
analysis of mothers and their offspring originating from northern
Finland, and in an independent case-control population of
offspring from southern Finland. Finally, we demonstrated that a
CAG repeat polymorphism present in exon 1 of the AR gene
associates with SPTB in the offspring. Therefore, our results
implicate AR as a potential fetal susceptibility gene for SPTB. The
role of AR in parturition timing remains to be investigated in
subsequent studies.
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